Refine
Year of publication
Document Type
- Preprint (686)
- Article (414)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (1102)
Is part of the Bibliography
- no (1102)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- Heavy-ion collision (6)
- Collective Flow (4)
- Jets (4)
- LHC (4)
- Quark-Gluon Plasma (4)
- ALICE experiment (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- breast cancer (3)
- Beauty production (2)
- COPD (2)
- Charm physics (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Heavy Quark Production (2)
- KGF (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- Nachsorge (2)
- PDGFRβ (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Polarization (2)
- QCD (2)
- ROS (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Sestrin 2 (2)
- Single electrons (2)
- Stroke (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- pp collisions (2)
- screening (2)
- 3D printing (1)
- 3D rapid prototyping (1)
- ADHD (1)
- ALICE detector (1)
- ARDS (1)
- ATAD2 (1)
- Alternating Phase Focusing (1)
- Andexanet alpha (1)
- Anti-nuclei (1)
- Apixaban (1)
- Atrial appendage occlusion (1)
- Atrial fibrillation (1)
- BRD2 (1)
- BRD4 (1)
- BROMO-10 (1)
- Beam dynamics simulation (1)
- Biodiversity conservation (1)
- Boosted Jets (1)
- Brain ischemia (1)
- COVID-19 (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charmonia (1)
- Collective Flow, (1)
- Community dynamics (1)
- Continuous wave (1)
- Critical care (1)
- Dabigatran (1)
- Di-hadron correlations (1)
- Diagnostic differentiation (1)
- ERK inhibitor (1)
- Edoxaban (1)
- Elastic scattering (1)
- Electrogena (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Fibre/foam sandwich radiator (1)
- Flow (1)
- Foramen ovale (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy ion (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- Idarucizumab (1)
- Individual based modeling (1)
- Interference fragmentation function (1)
- Intracranial embolism (1)
- Intracranial hemorrhage (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Isoscalar giant resonances (1)
- Jet Physics (1)
- Jet Substructure (1)
- Landscape genetics (1)
- Linear accelerator (1)
- Long distance movement (1)
- MEK inhibitor (1)
- MRI (1)
- Material budget (1)
- Minimum Bias (1)
- Mobile links (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-wire proportional drift chamber (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neural network (1)
- Nonflow (1)
- Noninferiority (1)
- Nonlinear beam dynamics (1)
- Outcome (1)
- PPARγ (1)
- Particle and Resonance Production (1)
- Production Cross Section (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RHIC (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Renal lesions (1)
- Resolution Parameter (1)
- Rivaroxaban (1)
- STAR (1)
- Species coexistence (1)
- Spin alignment (1)
- Storage ring (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transversity (1)
- Trigger (1)
- Vector Boson Production (1)
- Xenon-based gas mixture (1)
- androgen receptor (1)
- attention (1)
- bromodomain inhibitor (1)
- castration-resistant prostate cancer (1)
- chromatin (1)
- conservative dentistry (1)
- dE/dx (1)
- dental education (1)
- detector (1)
- drug resistance (1)
- experimental results (1)
- habitat selection (1)
- heavy ion experiments (1)
- hyperactivity (1)
- impulsivity (1)
- marked lymph node (1)
- metabolic syndrome (1)
- metastasis (1)
- montelukast (1)
- mouse tumor model (1)
- neoadjuvant therapy (1)
- oncogenic RAS (1)
- pancreatic ductal adenocarcinoma (1)
- patent (1)
- polygenic risk score (1)
- polypharmacology (1)
- pranlukast (1)
- quark gluon plasma (1)
- simulation training (1)
- soluble epoxide hydrolase (1)
- substance abuse disorder (1)
- targeted axillary dissection (1)
- taxonomy (1)
- therapy response (1)
- undifferentiated pleomorphic sarcoma (1)
- venturesomeness (1)
- zafirlukast (1)
Institute
- Physik (1076)
- Frankfurt Institute for Advanced Studies (FIAS) (944)
- Informatik (907)
- Medizin (17)
- Informatik und Mathematik (3)
- Pharmazie (3)
- ELEMENTS (2)
- Hochschulrechenzentrum (2)
- Senckenbergische Naturforschende Gesellschaft (1)
We present the first measurements of charge-dependent correlations on angular difference variables η1 − η2 (pseudorapidity) and φ1 − φ2 (azimuth) for primary charged hadrons with transverse momentum 0.15 <= pt <= 2 GeV/c and |η| <= 1.3 from Au–Au collisions at √sNN = 130 GeV. We observe correlation structures not predicted by theory but consistent with evolution of hadron emission geometry with increasing centrality from one-dimensional fragmentation of color strings along the beam direction to an at least two-dimensional hadronization geometry along the beam and azimuth directions of a hadron-opaque bulk medium.
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
(2017)
Global changes in chromatin accessibility may drive cancer progression by reprogramming transcription factor (TF) binding. In addition, histone acetylation readers such as bromodomain-containing protein 4 (BRD4) have been shown to associate with these TFs and contribute to aggressive cancers including prostate cancer (PC). Here, we show that chromatin accessibility defines castration-resistant prostate cancer (CRPC). We show that the deregulation of androgen receptor (AR) expression is a driver of chromatin relaxation and that AR/androgen-regulated bromodomain-containing proteins (BRDs) mediate this effect. We also report that BRDs are overexpressed in CRPCs and that ATAD2 and BRD2 have prognostic value. Finally, we developed gene stratification signature (BROMO-10) for bromodomain response and PC prognostication, to inform current and future trials with drugs targeting these processes. Our findings provide a compelling rational for combination therapy targeting bromodomains in selected patients in which BRD-mediated TF binding is enhanced or modified as cancer progresses.